HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hualiang Jiang Selected Research

COVID-19

10/2023Structure-based development and preclinical evaluation of the SARS-CoV-2 3C-like protease inhibitor simnotrelvir.
1/2023A viral RNA-dependent RNA polymerase inhibitor VV116 broadly inhibits human coronaviruses and has synergistic potency with 3CLpro inhibitor nirmatrelvir.
1/2023Bioactive compounds from Huashi Baidu decoction possess both antiviral and anti-inflammatory effects against COVID-19.
12/2022In vitro and in vivo evaluation of the main protease inhibitor FB2001 against SARS-CoV-2.
10/2021Glycan Epitopes and Potential Glycoside Antagonists of DC-SIGN Involved in COVID-19: In Silico Study.
10/2021Effects of Shuanghuanglian oral liquids on patients with COVID-19: a randomized, open-label, parallel-controlled, multicenter clinical trial.
1/2021Structural basis for inhibition of the SARS-CoV-2 RNA polymerase by suramin.
1/2021Beneficial effects exerted by hydroxychloroquine in treating COVID-19 patients via protecting multiple organs.
10/2020Low dose of hydroxychloroquine reduces fatality of critically ill patients with COVID-19.
10/2020Erratum to: Low dose of hydroxychloroquine reduces fatality of critically ill patients with COVID-19.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hualiang Jiang Research Topics

Disease

76Neoplasms (Cancer)
04/2024 - 05/2004
16Inflammation (Inflammations)
11/2023 - 12/2004
13Alzheimer Disease (Alzheimer's Disease)
10/2022 - 11/2003
12Leukemia
02/2023 - 02/2007
12Infections
10/2021 - 02/2005
10COVID-19
10/2023 - 10/2020
9Carcinogenesis
01/2022 - 05/2008
8Type 2 Diabetes Mellitus (MODY)
01/2022 - 01/2007
7Breast Neoplasms (Breast Cancer)
05/2022 - 04/2010
6Amyloid Plaque
11/2017 - 04/2005
5Schizophrenia (Dementia Praecox)
01/2021 - 09/2007
4Heart Failure
02/2023 - 01/2013
4Renal Cell Carcinoma (Grawitz Tumor)
01/2021 - 12/2016
4Hepatocellular Carcinoma (Hepatoma)
12/2018 - 06/2008
4Hypertension (High Blood Pressure)
01/2013 - 12/2004
4Influenza in Birds (Avian Flu)
08/2012 - 06/2006
4Rupture
04/2007 - 09/2003
3Colorectal Neoplasms (Colorectal Cancer)
04/2024 - 07/2009
3Bites and Stings (Sting)
12/2023 - 01/2023
3Colitis
11/2022 - 01/2021
3Central Nervous System Diseases (CNS Diseases)
07/2022 - 10/2019
3Dyslipidemias (Dyslipidemia)
01/2022 - 12/2004
3Parkinson Disease (Parkinson's Disease)
01/2021 - 12/2013
3Ovarian Neoplasms (Ovarian Cancer)
01/2021 - 04/2010
3Pulmonary Arterial Hypertension
01/2021 - 06/2010
3Neoplasm Metastasis (Metastasis)
07/2020 - 06/2008
3Lymphoma (Lymphomas)
01/2020 - 11/2014
3Virus Diseases (Viral Diseases)
01/2020 - 09/2012
3Malaria
12/2017 - 01/2009
3Cardiovascular Diseases (Cardiovascular Disease)
11/2017 - 07/2011
3Obesity
01/2015 - 01/2007
3Insulin Resistance
01/2013 - 01/2011
3Human Influenza (Influenza)
09/2012 - 10/2010
3Metabolic Diseases (Metabolic Disease)
03/2011 - 01/2011
3Severe Acute Respiratory Syndrome
01/2008 - 06/2005
2Communicable Diseases (Infectious Diseases)
01/2023 - 01/2020
2Hyperlipidemias (Hyperlipidemia)
01/2022 - 11/2019
2Fibrosis (Cirrhosis)
01/2021 - 01/2013
2Catalepsy
10/2020 - 02/2018
2Critical Illness (Critically Ill)
10/2020 - 10/2020

Drug/Important Bio-Agent (IBA)

33Proteins (Proteins, Gene)FDA Link
02/2023 - 02/2005
10EnzymesIBA
05/2017 - 08/2005
9Peptide Hydrolases (Proteases)FDA Link
10/2023 - 03/2005
9MethyltransferasesIBA
02/2019 - 11/2014
8Glucose (Dextrose)FDA LinkGeneric
01/2020 - 07/2009
6Amyloid (Amyloid Fibrils)IBA
01/2022 - 09/2006
5Phosphotransferases (Kinase)IBA
12/2023 - 09/2012
5LigandsIBA
01/2021 - 06/2007
5Anti-Bacterial Agents (Antibiotics)IBA
02/2019 - 11/2006
5Neuraminidase (Sialidase)IBA
09/2012 - 06/2006
4Lysine (L-Lysine)FDA Link
02/2023 - 10/2015
4Glycoproteins (Glycoprotein)IBA
10/2021 - 02/2005
4Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
10/2021 - 04/2010
4Phosphodiesterase 5 InhibitorsIBA
01/2021 - 06/2010
4Arginine (L-Arginine)FDA Link
02/2019 - 12/2014
4Blood Glucose (Blood Sugar)IBA
10/2013 - 09/2006
3InterferonsIBA
12/2023 - 01/2023
3RNA (Ribonucleic Acid)IBA
10/2023 - 01/2021
3Messenger RNA (mRNA)IBA
10/2023 - 01/2015
3Antiviral Agents (Antivirals)IBA
01/2023 - 01/2021
3Dextran SulfateIBA
11/2022 - 01/2021
3AcetylcholinesteraseIBA
10/2022 - 03/2013
3Therapeutic UsesIBA
01/2022 - 06/2010
3CytokinesIBA
01/2022 - 01/2020
3Hydroxychloroquine (Plaquenil)FDA LinkGeneric
01/2021 - 10/2020
3Protein-Arginine N-Methyltransferases (Methyltransferase, Protein Arginine)IBA
01/2021 - 05/2017
3Sorting NexinsIBA
01/2021 - 01/2020
3G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
10/2020 - 01/2017
3nitroxolineIBA
02/2019 - 11/2017
3ErbB Receptors (EGF Receptor)IBA
01/2018 - 05/2004
3Histones (Histone)IBA
01/2017 - 02/2014
3Amyloid beta-PeptidesIBA
04/2013 - 04/2005
3huperzine AIBA
04/2013 - 11/2003
3Insulin (Novolin)FDA Link
01/2013 - 01/2007
3Zanamivir (Relenza)FDA Link
09/2012 - 10/2006
3Amyloid Precursor Protein Secretases (beta-Secretase)IBA
01/2012 - 03/2005
3PPAR gammaIBA
12/2008 - 12/2004
2Irinotecan (Camptosar)FDA LinkGeneric
04/2024 - 02/2007
2NucleotidesIBA
11/2023 - 01/2021
2N-methyladenosineIBA
10/2023 - 01/2015
2magnololIBA
01/2023 - 01/2011
2remdesivirIBA
12/2022 - 01/2021
2Peptidylprolyl Isomerase (Prolyl Isomerase)IBA
10/2022 - 06/2007
2Antineoplastic Agents (Antineoplastics)IBA
07/2022 - 07/2012
2Purinergic P1 Receptors (Adenosine Receptor)IBA
06/2022 - 11/2021
2Histone Deacetylases (Histone Deacetylase)IBA
11/2021 - 09/2010
2Apoptosis Regulatory ProteinsIBA
10/2021 - 04/2010
2Hormones (Hormone)IBA
10/2021 - 09/2012
2Type 5 Cyclic Nucleotide PhosphodiesterasesIBA
01/2021 - 01/2019
2Interleukin-6 (Interleukin 6)IBA
10/2020 - 01/2020
2Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
01/2020 - 01/2012
2SphingolipidsIBA
01/2020 - 01/2014
2Chloroquine (Aralen)FDA LinkGeneric
01/2020 - 09/2002
2CholesterolIBA
01/2020 - 08/2012
2Small Interfering RNA (siRNA)IBA
01/2020 - 08/2014

Therapy/Procedure

34Therapeutics
04/2024 - 05/2008
5Drug Therapy (Chemotherapy)
01/2020 - 06/2003
4Chinese Traditional Medicine (Traditional Chinese Medicine)
01/2023 - 11/2003
2Immunotherapy
10/2023 - 01/2022
2Artificial Respiration (Mechanical Ventilation)
10/2020 - 10/2020